Showing results (61-70 of 302) with videos related to

Sort By:
Pageof 31
Toxins|November 13, 2013
Association between free light chain levels, and disease progression and mortality in chronic kidney diseaseLucie Desjardins, Sophie Liabeuf, Aurélie Lenglet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2020
Impact of the dialysate acid component on haemodialysis mortality ratesCécile Couchoud, Thierry Hannedouche, Marc Bauwens, et al.
Nephrologie & Therapeutique|April 10, 2019
"Doctor, can I have less frequent injection with highly efficient treatment?" A patient centered study using an electronic choice-based conjoint analysis (ePRO) to assess real world preferences regarding erythropoiesis stimulating agent to treat anaemia in chronic kidney disease (PERCEPOLIS study)Cécile Vigneau, Gabriel Choukroun, Corinne Isnard-Bagnis, et al.
Transplant Immunology|May 11, 2020
Flow cytometry crossmatching to investigate kidney-biopsy-proven, antibody-mediated rejection in patients who develop de novo donor-specific antibodiesCédric Usureau, Valentine Jacob, Valentin Clichet, et al.
Molecular Immunology|March 5, 2021
Antibodies against HLA cross-reactivity groups: From single antigen bead assay to immunoinformatics interpretation of epitopesCédric Usureau, Edgar Lefèvre, Isabelle Top, et al.
Nephron. Clinical Practice|May 12, 2005
Fabry disease in patients with end-stage renal failure: the potential benefits of screeningSoumeya Bekri, Adrian Enica, Thomas Ghafari, et al.
Nephrologie & Therapeutique|December 3, 2014
[QuiPO: who inject EPO?]Cécile Vigneau, Sylvie Le Stum, Corinne Isnard-Bagnis, et al.
Nephrologie & Therapeutique|December 3, 2014
[Fanconi syndrome in a 22-year-old African patient]Morgane Wetzstein, Maïté Jauréguy, Jean-Philippe Lanoix, et al.
Toxins|May 27, 2022
The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney InjuryPauline Caillard, Youssef Bennis, Isabelle Six, et al.
Advances in Therapy|February 7, 2023
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Frank Dellanna, Jose Portoles, et al.
Pageof 31